EVFM
Evofem Biosciences, Inc.Company with tickers: EVFM
CIK
1618835
CUSIP
30048L302
Shares Outstanding
132,530,081
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2020-01-02 | File Justin J. |
Chief Financial Officer | Sell | 3,352 |
| 2020-01-02 | PELLETIER SAUNDRA L |
Director, Chief Executive Officer | Sell | 6,705 |
| 2020-01-13 | PELLETIER SAUNDRA L |
Director, Chief Executive Officer | Sell | 3,295 |
| 2020-01-13 | File Justin J. |
Chief Financial Officer | Sell | 1,648 |
| 2020-01-16 | Barrans Russell |
Chief Commercial Officer | Sell | 1,578 |
| 2020-01-16 | Barrans Russell |
Chief Commercial Officer | Other | 279 |
| 2020-02-05 | Barrans Russell |
Chief Commercial Officer | Award | 899 |
| 2020-02-05 | Barrans Russell |
Chief Commercial Officer | Other | 279 |
| 2020-02-05 | Culwell Kelly |
Chief Medical Officer | Award | 150,000 |
| 2020-02-05 | Fitzpatrick Alexander A |
General Counsel and Secretary | Award | 150,000 |
| 2020-02-05 | Fitzpatrick Alexander A |
General Counsel and Secretary | Award | 100,000 |
| 2020-02-05 | Culwell Kelly |
Chief Medical Officer | Award | 100,000 |
| 2020-02-05 | File Justin J. |
Chief Financial Officer | Award | 150,000 |
| 2020-02-05 | Barrans Russell |
Chief Commercial Officer | Award | 100,000 |
| 2020-02-05 | PELLETIER SAUNDRA L |
Director, Chief Executive Officer | Award | 300,000 |
| 2020-02-05 | Culwell Kelly |
Chief Medical Officer | Award | 3,688 |
| 2020-02-05 | PELLETIER SAUNDRA L |
Director, Chief Executive Officer | Award | 300,000 |
| 2020-02-05 | Barrans Russell |
Chief Commercial Officer | Award | 150,000 |
| 2020-02-05 | File Justin J. |
Chief Financial Officer | Award | 100,000 |
| 2020-02-05 | PELLETIER SAUNDRA L |
Director, Chief Executive Officer | Award | 3,846 |
| 2020-02-05 | File Justin J. |
Chief Financial Officer | Award | 3,846 |
| 2020-02-19 | Culwell Kelly |
Chief Medical Officer | Sell | 1,000 |
| 2020-02-19 | Barrans Russell |
Chief Commercial Officer | Sell | 14,957 |
| 2020-02-19 | Barrans Russell |
Chief Commercial Officer | Other | 279 |
| 2020-02-25 | Rarick Lisa Dale |
Director | Award | 75,000 |
| 2020-02-25 | Rarick Lisa Dale |
Director | Other | 0 |
| 2020-03-31 | Lynch Thomas G |
Director | Convert | 37,500 |
| 2020-03-31 | Lynch Thomas G |
Director | Convert | 37,500 |
| 2020-04-01 | Lynch Thomas G |
Director | Award | 150,000 |
| 2020-04-30 | Culwell Kelly |
Chief Medical Officer | Sell | 1,000 |
| 2020-05-01 | Culwell Kelly |
Chief Medical Officer | Sell | 1,000 |
| 2020-05-06 | Culwell Kelly |
Chief Medical Officer | Tax | 7,792 |
| 2020-05-06 | File Justin J. |
Chief Financial Officer | Tax | 8,420 |
| 2020-05-06 | Fitzpatrick Alexander A |
General Counsel and Secretary | Tax | 7,802 |
| 2020-05-06 | Barrans Russell |
Chief Commercial Officer | Tax | 3,802 |
| 2020-05-06 | Barrans Russell |
Chief Commercial Officer | Other | 279 |
| 2020-05-06 | PELLETIER SAUNDRA L |
Director, Chief Executive Officer | Tax | 16,905 |
| 2020-05-12 | Rutherford Colin |
Director | Award | 50,000 |
| 2020-05-12 | O'Brien Anthony Stephen |
Director | Award | 50,000 |
| 2020-05-12 | Greer Gillian |
Director | Award | 50,000 |
| 2020-05-12 | Kamdar Kim P. |
Director | Award | 50,000 |
| 2020-05-12 | Rarick Lisa Dale |
Director | Award | 50,000 |
| 2020-05-12 | Hall William Walmsley |
Director | Award | 50,000 |
| 2020-05-14 | Invesco Ltd. |
10% Owner | Other | 78,013 |
| 2020-05-15 | Invesco Ltd. |
10% Owner | Sell | 3,211 |
| 2020-05-21 | PDL BIOPHARMA, INC. |
10% Owner | Other | 13,333,334 |
| 2020-05-22 | PELLETIER SAUNDRA L |
Director, Chief Executive Officer | Tax | 84,525 |
| 2020-05-22 | Culwell Kelly |
Chief Medical Officer | Tax | 39,435 |
| 2020-05-22 | Barrans Russell |
Chief Commercial Officer | Tax | 19,474 |
| 2020-05-22 | Fitzpatrick Alexander A |
General Counsel and Secretary | Tax | 39,487 |
Showing 1–50 of 136 transactions